Lexaria Bioscience Statistics
Total Valuation
LEXX has a market cap or net worth of $23.56 million. The enterprise value is $22.35 million.
Important Dates
The next estimated earnings date is Friday, January 9, 2026.
| Earnings Date | Jan 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LEXX has 22.23 million shares outstanding. The number of shares has increased by 45.34% in one year.
| Current Share Class | 22.23M |
| Shares Outstanding | 22.23M |
| Shares Change (YoY) | +45.34% |
| Shares Change (QoQ) | +6.98% |
| Owned by Insiders (%) | 4.99% |
| Owned by Institutions (%) | 7.73% |
| Float | 20.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 28.56 |
| Forward PS | 59.32 |
| PB Ratio | 7.33 |
| P/TBV Ratio | 9.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 31.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.32 |
| Quick Ratio | 1.56 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -232.15% and return on invested capital (ROIC) is -138.38%.
| Return on Equity (ROE) | -232.15% |
| Return on Assets (ROA) | -111.49% |
| Return on Invested Capital (ROIC) | -138.38% |
| Return on Capital Employed (ROCE) | -433.81% |
| Revenue Per Employee | $100,846 |
| Profits Per Employee | -$1.70M |
| Employee Count | 7 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.07% in the last 52 weeks. The beta is 0.62, so LEXX's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -59.07% |
| 50-Day Moving Average | 1.00 |
| 200-Day Moving Average | 1.10 |
| Relative Strength Index (RSI) | 49.83 |
| Average Volume (20 Days) | 143,420 |
Short Selling Information
The latest short interest is 651,519, so 2.93% of the outstanding shares have been sold short.
| Short Interest | 651,519 |
| Short Previous Month | 741,082 |
| Short % of Shares Out | 2.93% |
| Short % of Float | 3.14% |
| Short Ratio (days to cover) | 2.79 |
Income Statement
In the last 12 months, LEXX had revenue of $705,923 and -$11.90 million in losses. Loss per share was -$0.66.
| Revenue | 705,923 |
| Gross Profit | 703,203 |
| Operating Income | -11.63M |
| Pretax Income | -11.91M |
| Net Income | -11.90M |
| EBITDA | -11.55M |
| EBIT | -11.63M |
| Loss Per Share | -$0.66 |
Full Income Statement Balance Sheet
The company has $1.97 million in cash and $109,320 in debt, giving a net cash position of $1.86 million or $0.08 per share.
| Cash & Cash Equivalents | 1.97M |
| Total Debt | 109,320 |
| Net Cash | 1.86M |
| Net Cash Per Share | $0.08 |
| Equity (Book Value) | 2.60M |
| Book Value Per Share | 0.15 |
| Working Capital | 1.97M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$10.45 million and capital expenditures -$24,646, giving a free cash flow of -$10.48 million.
| Operating Cash Flow | -10.45M |
| Capital Expenditures | -24,646 |
| Free Cash Flow | -10.48M |
| FCF Per Share | -$0.47 |
Full Cash Flow Statement Margins
| Gross Margin | 99.61% |
| Operating Margin | -1,647.97% |
| Pretax Margin | -1,687.36% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LEXX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -45.34% |
| Shareholder Yield | -45.34% |
| Earnings Yield | -49.17% |
| FCF Yield | -43.28% |
Analyst Forecast
The average price target for LEXX is $4.00, which is 277.36% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 277.36% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 187.64% |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on January 12, 2021. It was a reverse split with a ratio of 1:30.
| Last Split Date | Jan 12, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
LEXX has an Altman Z-Score of -18.1 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -18.1 |
| Piotroski F-Score | 3 |